Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.

Neurohormones help control skin health and could treat skin disorders.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Androgens and other hormones affect hair growth and skin conditions like acne.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Testosterone therapy increases bone density in older men with low testosterone levels.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.